Anhui Fengyuan Pharmaceutical Co Ltd
000153
Company Profile
Business description
Anhui Fengyuan Pharmaceutical Co Ltd operates in pharmaceutical research and development, production, and sales. The business of the company includes preparations, API, health care, and commercial logistics. The company is engaged in development of bio innovative drugs and in set up of drug distribution branches.
Contact
No. 108, Beimenwai Street
Wuwei County
Anhui Province
Hefei230051
CHNT: +86 55164846153
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
4,542
Stocks News & Analysis
stocks
Market Minute: RBA cuts rates again, US CPI data released
This week, the RBA cut rates after a surprise hold in July; CBA reported earnings ; US inflation data came out, showing its highest reading since February.
stocks
Is the market still overlooking Alibaba’s AI potential?
Despite a 40% share price rally this year, investors could still be underestimating Alibaba’s cloud growth prospects.
stocks
ASX reporting season wrap: CBA, JB Hi-Fi, REA and more
A round up of notable stories and reactions as ASX earnings season gathers steam.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,212.10 | 63.00 | 0.69% |
CAC 40 | 7,923.45 | 53.11 | 0.67% |
DAX 40 | 24,359.30 | 18.20 | -0.07% |
Dow JONES (US) | 44,946.12 | 34.86 | 0.08% |
FTSE 100 | 9,138.90 | 38.34 | -0.42% |
HKSE | 25,270.07 | 249.25 | -0.98% |
NASDAQ | 21,622.98 | 87.69 | -0.40% |
Nikkei 225 | 43,378.31 | 729.05 | 1.71% |
NZX 50 Index | 12,889.38 | 55.30 | 0.43% |
S&P 500 | 6,449.80 | 18.74 | -0.29% |
S&P/ASX 200 | 8,938.60 | 64.80 | 0.73% |
SSE Composite Index | 3,696.77 | 30.33 | 0.83% |